The news: Abridge, a generative AI (genAI) startup that transcribes clinical conversations for documentation purposes, is raising $250 million at a valuation of $2.5 billion, according to a recent report in The Information.

Trendspotting: Amid all the hype of buzzy AI tools that could drive greater efficiencies in healthcare, health system leaders likely view medical scribe platforms among the easiest solutions to generate value from.

As long as the AI documentation tools are accurate, they should generate cost savings for organizations compared with the salary of a human scribe. For organizations that don’t employ medical scribes, AI provides a way for health system execs to relieve overburdened doctors since the tech could save them hours of time-consuming documentation each week.